Cover Image
Market Research Report

China Pharmaceuticals & Healthcare Q4 2019

Published by Fitch Solutions, Inc. Product code 209173
Published Content info 97 Pages
Delivery time: 1-2 business days
Price
Back to Top
China Pharmaceuticals & Healthcare Q4 2019
Published: August 6, 2019 Content info: 97 Pages
Description

Key View:

China will continue to benefit from significant investment from the innovative pharmaceutical industry. While the Chinese pharmaceutical market continues to face uncertainty on the back of challenges around drug pricing and the low levels of intellectual property protection, we maintain our view that it presents one of the most attractive investment destinations in the Asia Pacific region. Underpinning this view, China boasts a number of inherent advantages that makes it well positioned for continued FDI flows into the pharmaceutical sector. These include: a rapidly ageing population, a well-established manufacturing industry for pharmaceuticals and notable government commitment to sector development.

Table of Contents
Product Code: SSCN03_20191001

Table of Contents

Key View

SWOT

Industry Forecast

  • Pharmaceutical Market Forecast
  • Healthcare Market Forecast
  • Prescription Drug Market Forecast
  • Patented Drug Market Forecast
  • Generic Drug Market Forecast
  • OTC Medicine Market Forecast
  • Pharmaceutical Trade Forecast

Industry Risk/Reward Index

  • Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
  • Innovative Pharmaceuticals Risk/Reward Index

Regulatory Development

  • Regulatory Review
  • 13th Five-Year Plan: Key Points

Market Overview

Competitive Landscape

Company Profile

  • AstraZeneca
  • Bayer HealthCare
  • China Shijiazhuang Pharmaceutical Group (CSPC)
  • Eli Lilly (Lilly China)
  • GlaxoSmithKline
  • MSD
  • Merck KGaA
  • North China Pharmaceutical Corporation
  • Novartis
  • Pfizer
  • Roche
  • Sanofi
  • Shanghai Pharmaceuticals Holding Co
  • Sinopharm

China Demographic Outlook

Pharmaceuticals & Healthcare Glossary

Pharmaceuticals & Healthcare Methodology

Back to Top